Ironwood Pharmaceuticals (IRWD) Market Capitalization (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Market Capitalization across 17 years of filings, most recently posting $695.7 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 494.82% year-over-year to $695.7 million; the TTM figure through Jun 2026 stood at $695.7 million (up 494.82% YoY), while the FY2025 annual figure was $549.5 million, down 22.57% from the prior year.
• Market Capitalization came in at $695.7 million for Q2 2026 at Ironwood Pharmaceuticals, up from $577.8 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $2.0 billion in Q1 2022 to a low of $117.0 million in Q2 2025.
• Average Market Capitalization over 5 years is $1.1 billion, with a median of $1.2 billion recorded in 2024.
• Year-over-year, Market Capitalization plunged 88.77% in 2025 and jumped 494.82% in 2026.
• Over 5 years, Market Capitalization stood at $1.9 billion in 2022, then decreased by 6.27% to $1.8 billion in 2023, then tumbled by 60.32% to $709.7 million in 2024, then slipped by 22.57% to $549.5 million in 2025, then gained by 26.6% to $695.7 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $695.7 million in Q2 2026, $577.8 million in Q1 2026, and $549.5 million in Q4 2025.